| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..10519944B |
| P356 | DOI | 10.1073/PNAS.0808116105 |
| P932 | PMC publication ID | 2588415 |
| P698 | PubMed publication ID | 19036930 |
| P5875 | ResearchGate publication ID | 23500739 |
| P50 | author | Timothy P Sheahan | Q88410103 |
| Amy C Sims | Q88410106 | ||
| Eric Donaldson | Q90822619 | ||
| Barry Rockx | Q92024521 | ||
| Raymond J Pickles | Q114519286 | ||
| Mark R. Denison | Q56426185 | ||
| Rachel L. Graham | Q56863434 | ||
| Ralph S. Baric | Q63881333 | ||
| P2093 | author name string | Michelle M Becker | |
| Robert E Johnston | |||
| Davide Corti | |||
| P2860 | cites work | The molecular biology of coronaviruses | Q93899306 |
| Reconstitution of an infectious human endogenous retrovirus | Q21559512 | ||
| Host range and emerging and reemerging pathogens | Q24273386 | ||
| Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats | Q24536078 | ||
| Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides | Q24618245 | ||
| The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization | Q24817089 | ||
| Bats: important reservoir hosts of emerging viruses | Q27473464 | ||
| Viral evolution and the emergence of SARS coronavirus | Q27477755 | ||
| Structural basis of viral invasion: lessons from paramyxovirus F | Q27481675 | ||
| A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 | Q28191005 | ||
| Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 | ||
| Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome | Q28265807 | ||
| Bats are natural reservoirs of SARS-like coronaviruses | Q28274751 | ||
| Characterization of the reconstructed 1918 Spanish influenza pandemic virus | Q28275911 | ||
| Detection of group 1 coronaviruses in bats in North America | Q28752516 | ||
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
| A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 | ||
| Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China | Q29618055 | ||
| NCBI Reference Sequence project: update and current status | Q30722205 | ||
| Social and environmental risk factors in the emergence of infectious diseases | Q30977705 | ||
| A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice | Q33269158 | ||
| Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier | Q33793489 | ||
| Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template | Q33960127 | ||
| Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms | Q33987404 | ||
| The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication | Q34092836 | ||
| Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs | Q34228602 | ||
| Structure of SARS coronavirus spike receptor-binding domain complexed with receptor | Q34451350 | ||
| Switching species tropism: an effective way to manipulate the feline coronavirus genome | Q34857052 | ||
| Antibodies to SARS coronavirus in civets | Q35881133 | ||
| Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice | Q35914462 | ||
| Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion | Q36424092 | ||
| Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions | Q36447896 | ||
| Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin | Q36483269 | ||
| Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium | Q36483886 | ||
| Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge | Q36498144 | ||
| Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus | Q36690054 | ||
| A translation-attenuating intraleader open reading frame is selected on coronavirus mRNAs during persistent infection | Q36724120 | ||
| Emerging viruses: coming in on a wrinkled wing and a prayer | Q36728070 | ||
| A review of studies on animal reservoirs of the SARS coronavirus | Q36798770 | ||
| Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins | Q37492491 | ||
| The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells | Q39756274 | ||
| A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. | Q40073664 | ||
| Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain | Q40090304 | ||
| The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. | Q40106974 | ||
| Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. | Q40163145 | ||
| Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists | Q40208162 | ||
| 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase | Q40335972 | ||
| Mosaic evolution of the severe acute respiratory syndrome coronavirus | Q40377013 | ||
| Is CD46 the cellular receptor for measles virus? | Q41461720 | ||
| Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane | Q42624738 | ||
| Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. | Q42844863 | ||
| Animal models and vaccines for SARS-CoV infection | Q43152086 | ||
| Molecular constraints to interspecies transmission of viral pathogens | Q43218456 | ||
| Is there an ideal animal model for SARS? | Q51806996 | ||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coronaviridae | Q1134583 |
| SARSr-CoV | Q278567 | ||
| SARS-CoV-1 | Q85438966 | ||
| bat coronavirus | Q88099582 | ||
| P304 | page(s) | 19944-19949 | |
| P577 | publication date | 2008-11-26 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice | |
| P478 | volume | 105 |
| Q36702376 | A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence |
| Q36281179 | A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection |
| Q30374709 | A comprehensive collection of systems biology data characterizing the host response to viral infection. |
| Q98623621 | A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction |
| Q28817689 | A decade after SARS: strategies for controlling emerging coronaviruses |
| Q35531454 | A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge |
| Q36456720 | A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease |
| Q30360627 | A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant |
| Q31126174 | A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses |
| Q27490484 | A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo |
| Q93028017 | Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference |
| Q39730973 | An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system |
| Q91610063 | An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice |
| Q95315888 | Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection |
| Q37713866 | Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity |
| Q96302798 | Bat-borne virus diversity, spillover and emergence |
| Q42258730 | Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting |
| Q38665457 | Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. |
| Q84315401 | Broad-spectrum coronavirus antiviral drug discovery |
| Q103836662 | Building genomes to understand biology |
| Q91717735 | COVID-19: Risk Groups, Mechanistic Insights, and Challenges |
| Q41921793 | Cloning, Assembly, and Modification of the Primary Human Cytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated Recombination. |
| Q30244811 | Coronavirus Spike Protein and Tropism Changes |
| Q34663663 | Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments |
| Q34233548 | Coronavirus pathogenesis |
| Q26863163 | Coronavirus reverse genetic systems: infectious clones and replicons |
| Q33694361 | Coronaviruses post-SARS: update on replication and pathogenesis |
| Q35079166 | Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity |
| Q30250231 | Deciphering the biology of porcine epidemic diarrhea virus in the era of reverse genetics. |
| Q98720898 | Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding |
| Q34184711 | Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization |
| Q34983662 | Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses |
| Q36931120 | Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses |
| Q33644581 | Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana |
| Q24337838 | Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus |
| Q30355171 | Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. |
| Q40200075 | Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses |
| Q37962354 | Emerging biomedical applications of synthetic biology |
| Q37174550 | Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate |
| Q58596644 | Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform |
| Q37635133 | Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses |
| Q36023052 | Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats |
| Q28712758 | Evidence supporting a zoonotic origin of human coronavirus strain NL63 |
| Q90632605 | Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2 |
| Q96641812 | For a better world: Biosafety strategies to protect global health |
| Q89866691 | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses |
| Q84082454 | Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV |
| Q41012567 | Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus |
| Q30400728 | Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus |
| Q28748910 | Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences |
| Q84315382 | Geographical structure of bat SARS-related coronaviruses |
| Q64091639 | Harnessed viruses in the age of metagenomics and synthetic biology: an update on infectious clone assembly and biotechnologies of plant viruses |
| Q84316162 | Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China |
| Q33743774 | Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China |
| Q39436807 | Identification of immunogenic determinants of the spike protein of SARS-like coronavirus |
| Q39826024 | Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. |
| Q40293033 | Immunogenicity of a multi-epitope DNA vaccine against hantavirus |
| Q36154930 | Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus |
| Q33576672 | Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing |
| Q93221320 | Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 |
| Q90465443 | Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics? |
| Q30219701 | Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor |
| Q30235867 | Jumping species-a mechanism for coronavirus persistence and survival |
| Q34417984 | Large-scale de novo DNA synthesis: technologies and applications |
| Q34416671 | Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat |
| Q34282268 | Methods and applications for assembling large DNA constructs |
| Q57094095 | Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice |
| Q87747946 | Origin and evolution of pathogenic coronaviruses |
| Q33813376 | Proof by synthesis of Tobacco mosaic virus |
| Q36509100 | Protecting society. Biological security and dual-use dilemma in the life sciences--status quo and options for the future |
| Q43692542 | Public health: Broad reception for coronavirus |
| Q24650468 | Putting synthesis into biology: a viral view of genetic engineering through de novo gene and genome synthesis |
| Q33963398 | RNA virus reverse genetics and vaccine design. |
| Q35943657 | Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence |
| Q38133141 | Receptor recognition and cross-species infections of SARS coronavirus |
| Q88974047 | Recombination and lineage-specific mutations led to the emergence of SARS-CoV-2 |
| Q37631303 | Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission |
| Q38254831 | Reprint of: Coronavirus reverse genetic systems: infectious clones and replicons. |
| Q88046426 | Return of the Coronavirus: 2019-nCoV |
| Q37218442 | Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus |
| Q30249325 | SARS and MERS: recent insights into emerging coronaviruses |
| Q35612506 | SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission |
| Q60949221 | SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats () |
| Q40375905 | Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History |
| Q34073961 | Synthetic biology for translational research |
| Q59267606 | Synthetic biology: From the first synthetic cell to see its current situation and future development |
| Q33958771 | Synthetic biology: applications come of age |
| Q28729206 | Synthetic constructs in/for the environment: managing the interplay between natural and engineered Biology |
| Q28706666 | Synthetic genomics and synthetic biology applications between hopes and concerns |
| Q57566541 | Synthetic genomics: a new venture to dissect genome fundamentals and engineer new functions |
| Q57031417 | Synthetic viruses-Anything new? |
| Q24650817 | Synthetic viruses: a new opportunity to understand and prevent viral disease |
| Q38718445 | The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination |
| Q37542425 | The impact of synthetic biology on drug discovery |
| Q58494157 | The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species |
| Q37246874 | The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines |
| Q91697408 | Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection |
| Q37783762 | Update on SARS research and other possibly zoonotic coronaviruses |
| Q47253371 | Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses |
Search more.